Showing 18,161 - 18,180 results of 103,202 for search '(( 5 ((ng decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (nn decrease)) ))', query time: 1.38s Refine Results
  1. 18161

    The forest plots of the effect of probiotics on the level of IL-17 by ELISA (A), RT-PCR (B) and Flow cytometry (C) methods. by Zahra Zangeneh (11772967)

    Published 2025
    “…The overall level of IL-17 decreased after probiotic addition in ELISA test (overall Std diff in means = -3.578) (A), but increased following probiotic administration in RT-PCR (overall Std dif in means = 0.504) (B), and flow cytometry (overall Std dif in means = 5.298) (C).…”
  2. 18162

    Overlayed expression profiles of cyclins A2 and B1. by James W. Jacobberger (184625)

    Published 2012
    “…<p>Overlays of expression profiles for PHH3 (A, B) from the data set Molt4 cells stained for cyclin A2, PHH3, and DNA content (labeled PHH3 from A2) presented in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0030870#pone-0030870-g005" target="_blank">Figure 5</a>, and from cells stained for cyclin B1, PHH3, and DNA content (labeled PHH3 from B1). …”
  3. 18163

    Thermophoresis-Controlled Size-Dependent DNA Translocation through an Array of Nanopores by Miao Zhang (17216)

    Published 2018
    “…Large arrays of nanopores can be used for high-throughput biomolecule translocation with applications toward size discrimination and sorting at the single-molecule level. In this paper, we propose to discriminate DNA length by the capture rate of the molecules to an array of relatively large nanopores (50–130 nm) by introducing a thermal gradient by laser illumination in front of the pores balancing the force from an external electric field. …”
  4. 18164

    A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease A... by Christopher J. Counts (727248)

    Published 2015
    “…Furthermore, the 77I93V covariant enhanced precursor autoprocessing and Gag polyprotein processing but decreased the mature PR activity. …”
  5. 18165

    Tonic nM DA stabilizes the timing of LP activity over the short term. by Wulf-Dieter C. Krenz (693267)

    Published 2015
    “…<p><b>(A) Pyloric output is altered by 1mM 4AP</b>. Representative experiments showing the motor output at three time points for a preparation continuously superfused with 1mM 4AP (blue) or 1mM 4AP + 5nM DA (green) beginning at t = 0. …”
  6. 18166
  7. 18167

    Regulation of USP2a and MDM2 in response to <i>as-</i>APF. (A by Jayoung Kim (153487)

    Published 2013
    “…<p>) <i>as-</i>APF downregulates USP2a expression (immunoblot). T24 cells were incubated with 1 µM <i>as</i>-APF or control peptides for the indicated times (0, 0.5, 1, 1.5, or 2 h). …”
  8. 18168

    Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

    Published 2017
    “…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC<sub>50</sub> = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC<sub>50</sub> value. …”
  9. 18169

    Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

    Published 2017
    “…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC<sub>50</sub> = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC<sub>50</sub> value. …”
  10. 18170

    Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

    Published 2017
    “…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC<sub>50</sub> = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC<sub>50</sub> value. …”
  11. 18171

    Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

    Published 2017
    “…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC<sub>50</sub> = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC<sub>50</sub> value. …”
  12. 18172

    Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

    Published 2017
    “…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC<sub>50</sub> = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC<sub>50</sub> value. …”
  13. 18173

    Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

    Published 2017
    “…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC<sub>50</sub> = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC<sub>50</sub> value. …”
  14. 18174

    Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

    Published 2017
    “…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC<sub>50</sub> = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC<sub>50</sub> value. …”
  15. 18175

    Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

    Published 2017
    “…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC<sub>50</sub> = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC<sub>50</sub> value. …”
  16. 18176

    TG2 protects HEK 293A cells from hyperosmotic stress, independent of its localization and conformation. by Soner Gundemir (371977)

    Published 2013
    “…LDH release is significantly decreased in HEK 293A cells which express TG2 regardless of the conformation state or its subcellular localization (N = 5). …”
  17. 18177

    Pre-trained feature aggregated deep learning-based monitoring of overshooting tops using multi-spectral channels of GeoKompsat-2A advanced meteorological imagery by Juhyun Lee (449913)

    Published 2021
    “…The best-performed scheme yielded a probability of detection (POD) of 92.1%, a false alarm ratio (FAR) of 21.5%, and a critical success index (CSI) of 0.7. …”
  18. 18178
  19. 18179
  20. 18180